Drug firm Granules India on Wednesday reported 8 per cent increase in consolidated profit after tax at Rs 130 crore for the fourth quarter ended March 31, 2024. The drug firm had posted a profit after tax (PAT) of Rs 120 crore for January-March FY23.
| Subscribe To Our Free Newsletter |
